Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04746300 | imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS(PROMPT) | unknown | — | 400 | Radboud University Medical CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04736108 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 50 | West China HospitalOTHER | 1 | Feb 8, 2021 |
| clinicaltrials |
| NCT03457805 | Prostatic Artery Embolization in Advanced Prostate Cancer | unknown | N/A | 20 | Dominik AbtOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT00667888 | A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | unknown | Phase 3 | 225 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03432780 | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer(QRT-SOGUG) | unknown | Phase 2 | 134 | Spanish Oncology Genito-Urinary GroupOTHER | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04699344 | A Prospective, Single-centre,Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | unknown | — | 500 | Qilu Hospital of Shandong UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04622761 | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome(CHROME) | unknown | Phase 2 | 120 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT04642833 | Prostate Cancer in Renal Transplants Recipients(RENPRO) | unknown | — | 30 | University of FlorenceOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT01835977 | Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer | unknown | Phase 2 | 106 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Dec 16, 2020 | clinicaltrials |
| NCT02255890 | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device | unknown | — | 361 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT00303784 | Prostate Adenocarcinoma TransCutaneous Hormones(PATCH) | unknown | Phase 3 | 2,200 | University College, LondonOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT01505075 | Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer(pHART8) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01953055 | SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)(SATURN) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02031328 | Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02911636 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR(5STAR) | unknown | N/A | 30 | Andrew LoblawOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT03307460 | uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness | unknown | Phase 2 | 52 | Rigshospitalet, DenmarkOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT04632251 | Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer(LPM-012) | unknown | N/A | 56 | Lightpoint Medical LimitedINDUSTRY | 4 | Nov 17, 2020 | clinicaltrials |
| NCT04586543 | Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma | unknown | Phase 2 | 110 | László MangelOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04034953 | Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong | unknown | N/A | 10,000 | Chinese University of Hong KongOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04577222 | The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy | unknown | N/A | 60 | Rabin Medical CenterOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04567875 | Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma(Apa-CARDIO1) | unknown | — | 54 | Ospedale Andrea Tortora di PaganiNETWORK | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04462926 | Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed(PSMA-PROSTAPET) | unknown | N/A | 100 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT02282137 | 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer(PSMA) | unknown | Phase 2 | 208 | Ebrahim DelpassandOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04507698 | INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer(INTERVAL) | unknown | N/A | 80 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03212456 | Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia | unknown | N/A | 146 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jul 29, 2020 | clinicaltrials |
| NCT03960112 | Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference(NPV-MRI-02) | unknown | N/A | 150 | Institut Paoli-CalmettesOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04489745 | Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer | unknown | Phase 2 | 72 | VA Greater Los Angeles Healthcare SystemFED | 0 | Jul 28, 2020 | clinicaltrials |
| NCT04486937 | SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation(mCRPC) | unknown | Phase 1 / Phase 2 | 90 | Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY | 0 | Jul 27, 2020 | clinicaltrials |
| NCT03934164 | Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO(MAESTRO) | unknown | — | 600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT04484038 | Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma | unknown | N/A | 300 | Grupo de Investigación Clínica en Oncología RadioterapiaOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer(PERSEUS1) | unknown | Phase 2 | 100 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT03857113 | Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study(TRACE) | unknown | — | 20 | The Netherlands Cancer InstituteOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04011865 | Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment | unknown | N/A | 80 | Binh Dan HospitalOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT02742675 | Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | unknown | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03380806 | Prostate Boost Irradiation With Stereotactic Body RT (SBRT)(PBS) | unknown | Phase 2 | 100 | Juravinski Cancer CenterOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01764646 | Hypofractionated Radiation Therapy in Prostate Cancer | unknown | N/A | 170 | Thomas ZilliOTHER | 8 | May 19, 2020 | clinicaltrials |
| NCT02691975 | A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 197 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 13, 2020 | clinicaltrials |
| NCT04369508 | PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy | unknown | — | 20 | Xuanwu Hospital, BeijingOTHER | 0 | Apr 30, 2020 | clinicaltrials |
| NCT00326638 | 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer | unknown | N/A | 72 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04102904 | The Prostate Liquid Study (PLiS)(PLiS) | unknown | — | 300 | University College, LondonOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04322045 | Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening | unknown | N/A | 10,000 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04320147 | MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer | unknown | N/A | 300 | Asan Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03787823 | RCT-evaluation of Retzius-sparing Robotic Prostatectomy | unknown | N/A | 186 | Heidelberg UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT04317625 | Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL | unknown | N/A | 232 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04297410 | 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease(NALuPROST) | unknown | N/A | 5 | Rabin Medical CenterOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04292041 | Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome | unknown | — | 40 | Galway ClinicNETWORK | 1 | Mar 2, 2020 | clinicaltrials |
| NCT04284020 | Educational Program Plus Physiotherapy After Prostatectomy | unknown | N/A | 84 | University of AlcalaOTHER | 1 | Feb 25, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Feb 9, 2021source: clinicaltrials